![Frontiers | Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment Frontiers | Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment](https://www.frontiersin.org/files/MyHome%20Article%20Library/494836/494836_Thumb_400.jpg)
Frontiers | Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment
![Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States - The Lancet Regional Health – Americas Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States - The Lancet Regional Health – Americas](https://www.thelancet.com/cms/attachment/0a6dab6b-0edc-406a-ae0d-5ef39064be4a/gr1.jpg)
Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States - The Lancet Regional Health – Americas
![Innate Immune Modulation in Chronic Obstructive Pulmonary Disease: Moving Closer toward Vitamin D Therapy | Journal of Pharmacology and Experimental Therapeutics Innate Immune Modulation in Chronic Obstructive Pulmonary Disease: Moving Closer toward Vitamin D Therapy | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/353/2/360/F1.large.jpg)